›› 2014, Vol. 29 ›› Issue (6): 603-606.DOI: 10.3969/j.issn.1673-8640.2014.06.006

Previous Articles     Next Articles

Homologous recombination knockout blaKPC-2 gene in clinical isolates of Klebsiella pneumonia

ZHANG Ying, TIAN Yueru, AI Fuqi, LIU Hong, MA Yimin, WANG Bei, JIANG Xiaofei   

  1. Department of Clinical Laboratory, Huashan Hospital, Fudan University, Shanghai 200040, China
  • Received:2014-01-16 Online:2014-06-30 Published:2014-06-23

Abstract: Objective To establish a method of knocking out drug-resistant genes on plasmid contained by clinical Klebsiella pneumonia drug-resistant isolates. Methods Polymerase chain reaction(PCR) was used to amplify the upstream and downstream fragments of target gene blaKPC-2 of the test isolates and hygromycin resistance gene fragments on plasmid pMQ300, respectively. Gene splicing by overlap extension polymerase chain reaction(SOE-PCR) was used to construct the fusion fragments, and apramycin resistance lambda red plasmid pKOBEG-Apr was used as mediated, homologous recombination knockout blaKPC-2 gene in clinical Klebsiella pneumonia drug-resistant isolates. LB medium containing hygromycin and apramycin was used to screen recombination, and PCR and reverse transcription-polymerase chain reaction(RT-PCR) amplification were used to detect blaKPC - 2 gene and hygromycin resistance gene, and drug sensitive test was used to confirm the recombination. Results The blaKPC-2 gene was successfully knocked out in 2 clinical Klebsiella pneumonia drug-resistant isolates with different multilocus sequence typing(MLST). Conclusions Lambda red homologous recombination method can be used to knock out clinical Klebsiella pneumonia drug-resistant isolate plasmid gene reliably.

Key words: Gene knockout, Homologous recombination, Klebsiella pneumonia

CLC Number: